(Journal Article): Adenovirus vectors: biology, design, and production.
 
Imperiale MJ, Kochanek S (Department of Microbiology and Immunology, Center for Gene Therapy, University of Michigan Medical School, 1500 E. Medical Center Drive, 6304 Cancer Center, Ann Arbor, MI 48109-0942, USA)
 
IN: Curr Top Microbiol Immunol 2004; 273:335-357
Impact Factor(s) of Curr Top Microbiol Immunol: 4.009 (2004), 2.977 (2003), 3.347 (2002), 3.554 (2001)

ABSTRACT: The use of adenovirus as a gene transfer vehicle arose from early reports of recombinant viruses carrying heterologous DNA fragments. Adenovirus vectors offer many advantages for gene delivery: they are easy to propagate to high titers, they can infect most cell types regardless of their growth state, and in their most recent embodiments they can accommodate large DNA inserts. In this chapter, the development of adenovirus vectors is reviewed, from the use of so-called first-generation, E1-deleted viruses to the latest generation high-capacity, helper-dependent vectors. Examples of their use in the clinic are described, as are the current areas in which improvements to these vectors are being explored.

TYPE OF PUBLICATION: Review

Articles citing this article:

• Emamaullee JA, Rajotte RV, Liston P, Korneluk RG, Lakey JR, Shapiro AM, Elliott JF. XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes. Diabetes 2005. 54: 2541-2548.
  » Diabetes OD » Regeneration of Islets » Transplantation » Islet Cells » Inhibition of Apoptosis » Journal Article